drugset / Trial / NCT02549196
A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Non-randomizedSingle-groupSingle-blindTreatment
Summary
This is a Phase II, ascending dose study of CPC-201 in patients with dementia of Alzheimer's type to determine the optimal dose titration schedule.
Timeline
- Start
- 2015-10-07
- Primary completion
- 2017-09-28
- Completion
- 2017-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 40 mg | — |
| Subject | Donepezil | Small molecule | 60 mg | — |
| Subject | Solifenacin | Small molecule | 15 mg | — |
| Subject | Solifenacin | Small molecule | 20 mg | — |